Citius Oncology, Inc. (CTOR)
$0.81-3.57%Close
SELLCRISIS · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $75M
- Beta
- 3.53
- P/E (TTM)
- -1.78
- Short % float
- 5.79%
- Days to cover
- 2.2
- SI change
- -43.1%
- 1W
- -6.90%
- 1M
- -11.96%
- vs SPY 1W
- -7.32%
- vs SPY 1M
- -14.02%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CTOR?
- LOPJLB’s latest quantitative signal on Citius Oncology, Inc. (CTOR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CTOR in?
- Citius Oncology, Inc. (CTOR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Citius Oncology, Inc. (CTOR) do?
- Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New Yo…